In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications

Canadian Journal of Microbiology

Volumn 58, Issue 6, 2012, Pages 776-787

  Sulemankhil, Imran ^a   Parent, Mathieu ^b   Jones, Mitchell Lawrence ^b   Feng, Zhenqian ^b   Labbé, Alain ^b   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Bacteria; Health food probiotics; Lactobacillus reuteri; Probiotics; Strain safety

Indexed keywords

BACTERIAL RNA; NCIMB 30253; PROBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG;

ANTIBIOTICS; BACTERIUM; BIOENGINEERING; BIOMARKER; FOOD CONSUMPTION; GENE EXPRESSION; GENETIC ANALYSIS; HEMATOLOGY; INHIBITOR; MOLECULAR ANALYSIS; PROBIOTICS; PROTEIN; SAFETY;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SCREENING; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS REUTERI; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SEQUENCE; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; GLYCERALDEHYDE; HUMANS; INTERLEUKIN-8; LACTOBACILLUS REUTERI; MALE; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; PROPANE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; LACTOBACILLUS REUTERI; RATTUS;

EID: 84861672622     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W2012-050     Document Type: Article

References (73)

1. Abe, F., Muto, M., Yaeshima, T., Iwatsuki, K., Aihara, H., Ohashi, Y., and Fujisawa, T. 2010. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe, 16(2): 131-136. doi:10.1016/j. anaerobe.2009.07.006. PMID:19638311.
2. Abrahamsson, T.R., Jakobsson, T., Bottcher, M.F., Fredrikson, M., Jenmalm, M.C., Bjorksten, B., and Oldaeus, G. 2007. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119(5): 1174-1180. doi:10.1016/j.jaci.2007.01.007. PMID:17349686.
3. Abrahamsson, T.R., Sinkiewicz, G., Jakobsson, T., Fredrikson, M., and Bjorksten, B. 2009. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J. Pediatr. Gastroenterol. Nutr. 49(3): 349-354. doi:10.1097/MPG. 0b013e31818f091b. PMID:19525871.
4. Aguirre, M., and Collins, M.D. 1993. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75(2): 95-107. doi:10.1111/j.1365-2672.1993.tb02753.x. PMID:8407678.
5. Anjani, K., Phillips, M., and Kailasapathy, K. 2006. Acceleration of cheddar cheese ripening with encapsulated enzymes. Aust. J. Dairy Technol. 61(2): 206.
6. Avonts, L., and De Vuyst, L. 2001. Antimicrobial potential of probiotic lactic acid bacteria. Meded. Rijksuniv. Gent Fak. Landbouwkd. Toegep. Biol. Wet. 66(3b): 543-550. PMID: 15954651.
7. Aziz, R.K., Bartels, D., Best, A.A., DeJongh, M., Disz, T., Edwards, R.A., et al. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics, 9(1): 75. doi:10.1186/ 1471-2164-9-75. PMID:18261238.
8. Barlow, S., Chesson, A., Collins, J.D., Dybing, E., Flynn, A., Fruijtier-Pölloth, C., et al. 2007. Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. EFSA J. 587: 1-16. doi:10. 2903/j.efsa.2007.587.
9. Becker, K., Southwick, K., Reardon, J., Berg, R., and MacCormack, J.N. 2001. Histamine poisoning associated with eating tuna burgers. JAMA, 285(10): 1327-1330. doi:10.1001/jama.285.10. 1327. PMID:11255388.
10. Bizani, D., and Brandelli, A. 2002. Characterization of a bacteriocin produced by a newly isolated Bacillus sp. strain 8 A. J. Appl. Microbiol. 93(3): 512-519. doi:10.1046/j.1365-2672.2002.01720.x. PMID:12174052.
11. Bover-Cid, S., and Holzapfel, W.H. 1999. Improved screening procedure for biogenic amine production by lactic acid bacteria. Int. J. Food Microbiol. 53(1): 33-41. doi:10.1016/S0168-1605(99) 00152-X. PMID:10598112.
12. Branton, W.B., Jones, M.L., Tomaro-Duchesneau, C., Martoni, C.J., and Prakash, S. 2011. In vitro characterization and safety of the probiotic strain Lactobacillus reuteri cardioviva NCIMB 30242. Int. J. Probiotics Prebiotics, 6: 1-12.
13. Cadieux, P., Wind, A., Sommer, P., Schaefer, L., Crowley, K., Britton, R.A., and Reid, G. 2008. Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl. Environ. Microbiol. 74(15): 4645-4649. doi:10.1128/AEM. 00139-08. PMID:18539802.
14. Champagne, C.P., Gardner, N.J., and Roy, D. 2005. Challenges in the addition of probiotic cultures to foods. Crit. Rev. Food Sci. Nutr. 45(1): 61-84. doi:10.1080/10408690590900144. PMID: 15730189.
15. Charteris, W.P., Kelly, P.M., Morelli, L., and Collins, J.K. 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84(5): 759-768. doi:10.1046/j.1365-2672.1998.00407.x. PMID:9674129.
16. Circle, S.J., Stone, L., and Boruff, C.S. 1945. Acrolein determination by means of tryptophane. A colorimetric micromethod. Ind. Eng. Chem. Anal. Ed. 17(4): 259-262. doi:10.1021/i560140a021.
17. Cleusix, V., Lacroix, C., Vollenweider, S., Duboux, M., and Le Blay, G. 2007. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 7(1): 101. doi:10.1186/1471-2180-7-101. PMID:17997816.
18. Connolly, E. 2004. Lactobacillus reuteri ATCC 55730 - a clinically proven probiotic. Nutrafoods, 3(1): 15-22.
19. Connolly, E., Abrahamsson, T., and Björkstén, B. 2005. Safety of D(-)-lactic acid producing bacteria in the human infant. J. Pediatr. Gastroenterol. Nutr. 41(4): 489-492. doi:10.1097/01. mpg.0000176179.81638.45. PMID:16205524.
20. Darling, A.E., Mau, B., and Perna, N.T. 2010. ProgressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS ONE, 5(6): e11147. doi:10.1371/journal.pone. 0011147. PMID:20593022.
21. de Vrese, M., and Barth, C.A. 1991. Postprandial plasma D-lactate concentrations after yogurt ingestion. Z. Ernahrungswiss. 30(2): 131-137. doi:10.1007/BF01610068. PMID:1897274.
22. Donnet-Hughes, A., Rochat, F., Serrant, P., Aeschlimann, J.M., and Schiffrin, E.J. 1999. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci. 82(5): 863-869. doi:10.3168/jds.S0022-0302(99)75304-X. PMID: 10342225.
23. EFSA. 2008. Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J. 732: 1-15. doi:10.2903/j.efsa.2008.732.
24. Eschenbach, D.A., Davick, P.R., Williams, B.L., Klebanoff, S.J., Young-Smith, K., Critchlow, C.M., and Holmes, K.K. 1989. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27(2): 251-256. PMID:2915019.
25. FAO/WHO. 2001.Health and nutritional properties of probiotic in food including powdered milk with lactic acid bacteria live. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO/WHO.
26. FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food report. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. FAO/WHO.
27. Fernández, M.F., Boris, S., and Barbés, C. 2005. Safety evaluation of Lactobacillus delbrueckii subsp. lactis UO 004, a probiotic bacterium. Res. Microbiol. 156(2): 154-160. doi:10.1016/j. resmic.2004.09.006. PMID:15748979.
28. Fraley, D.S., and Adler, S. 1976. Isohydric regulation of plasma potassium by bicarbonate in the rat. Kidney Int. 9(4): 333-343. doi:10.1038/ki.1976.39. PMID:7707.
29. Gasser, F. 1994. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur, 92(1): 45-67.
30. Gigante, A., Sardo, L., Gasperini, M.L., Molinaro, A., Riggio, O., Laviano, A., and Amoroso, A. 2012. D-Lactic acidosis 25 years after bariatric surgery due to Salmonella enteritidis. Nutrition, 28(1): 108-111. doi:10.1016/j.nut.2011.07.005. PMID:21996046.
31. Gill, H.S., and Guarner, F. 2004. Probiotics and human health: a clinical perspective. Postgrad. Med. J. 80(947): 516-526. doi:10. 1136/pgmj.2003.008664. PMID:15356352.
32. Grimoud, J., Durand, H., de Souza, S., Monsan, P., Ouarne, F., Theodorou, V., and Roques, C. 2010. In vitro screening of probiotics and synbiotics according to anti-inflammatory and antiproliferative effects. Int. J. Food Microbiol. 144(1): 42-50. doi:10. 1016/j.ijfoodmicro.2010.09.007. PMID:20951454.
33. Hammami, R., Zouhir, A., Ben Hamida, J., and Fliss, I. 2007. BACTIBASE: a new web-accessible database for bacteriocin characterization. BMC Microbiol. 7(1): 89. doi:10.1186/1471-2180-7-89. PMID:17941971.
34. Hove, H., and Mortensen, P.B. 1995. Colonic lactate metabolism and D-lactic acidosis. Dig. Dis. Sci. 40(2): 320-330. doi:10.1007/BF02065417. PMID:7851197.
35. International Organization for Standardization. 2010. Milk and milk products - determination of the minimal inhibitory concentration (MIC) of antibiotics applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB). ISO 10932:2010. International Organization for Standardization, Geneva, Switzerland.
36. Jones, M.L., Martoni, C.J., Parent, M., and Prakash, S. 2011. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br. J. Nutr. 1-9. doi:10.1017/S0007114511004703. PMID:22067612.
37. Kailasapathy, K. 2006. Survival of free and encapsulated probiotic bacteria and their effect on the sensory properties of yoghurt. LWT Food Sci. Technol. 39(10): 1221-1227. doi:10.1016/j.lwt.2005.07. 013.
38. Kelly, D., Campbell, J.I., King, T.P., Grant, G., Jansson, E.A., Coutts, A.G., et al. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-g and RelA. Nat. Immunol. 5(1): 104-112. doi:10.1038/ ni1018. PMID:14691478.
39. Klein, G., Bonaparte, C., and Reuter, G. 1992. Lactobacilli as starter cultures in the dairy industry under the aspect of safe biotechnology. Milchwissenschaft, 47(10): 632-636.
40. Ku, W.H., Lau, D.C.Y., and Huen, K.F. 2006. Probiotics provoked D-lactic acidosis in short bowel syndrome: case report and literature review. Hong Kong Journal of Paediatrics, 11: 246-254.
41. Kuleaşan, H., and Çakmakçi, M.L. 2002. Effect of reuterin produced by Lactobacillus reuteri on the surface of sausages to inhibit the growth of Listeria monocytogenes and Salmonella spp. Nahrung, 46(6): 408-410. doi:10.1002/1521-3803(20021101)46:6<408:: AID-FOOD408>3.0.CO;2-T. PMID:12577589.
42. Lapierre, L., Germond, J.E., Ott, A., Delley, M., and Mollet, B. 1999. D-Lactate dehydrogenase gene (ldhD) inactivation and resulting metabolic effects in the Lactobacillus johnsonii strains La1 and N312. Appl. Environ. Microbiol. 65(9): 4002-4007. PMID: 10473408.
43. Lemann, M., Bouhnik, Y., Corguille, M.K.L., Bonnet, J., Coffin, B., Marteau, P., et al. 1997. Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA). Gastroenterology, 112(4): A1025.
44. Liu, Y., Fatheree, N.Y., Mangalat, N., and Rhoads, J.M. 2010. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 299(5): G1087-G1096. doi:10.1152/ajpgi.00124. 2010. PMID:20798357.
45. Ma, D., Forsythe, P., and Bienenstock, J. 2004. Live Lactobacillus rhamnosus is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect. Immun. 72(9): 5308-5314. doi:10.1128/IAI.72.9.5308-5314.2004. PMID: 15322027.
46. Makras, L., and De Vuyst, L. 2006. The in vitro inhibition of Gramnegative pathogenic bacteria by bifidobacteria is caused by the production of organic acids. Int. Dairy J. 16(9): 1049-1057. doi:10.1016/j.idairyj.2005.09.006.
47. Maragkoudakis, P.A., Papadelli, M., Georgalaki, M., Panayotopoulou, E.G., Martinez-Gonzalez, B., Mentis, A.F., et al. 2009. In vitro and in vivo safety evaluation of the bacteriocin producer Streptococcus macedonicus ACA-DC 198. Int. J. Food Microbiol. 133(1-2): 141-147. doi:10.1016/j.ijfoodmicro.2009.05.012. PMID:19515446.
48. Marteau, P. 2001. Safety aspects of probiotic products. Scand. J. Nutr. 45: 22-24.
49. Marteau, P., Minekus, M., Havenaar, R., and Huis In't Veld, J.H.J. 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J. Dairy Sci. 80(6): 1031-1037. doi:10.3168/jds.S0022-0302(97) 76027-2. PMID:9201571.
50. McFarland, J. 1907. Nephelometer: an instrument for estimating the number of bacteria in suspension used for calculating the opsonic index for vaccines. J. Am. Med. Assoc. 49(14): 1176-1178. doi:10.1001/jama.1907.25320140022001f.
51. Michie, S., Bron, F., Bobrow, M., and Marteau, T.M. 1997. Nondirectiveness in genetic counseling: an empirical study. Am. J. Hum. Genet. 60(1): 40-47. PMID:8981945.
52. Miki, M., Ishikawa, T., and Okayama, H. 2005. An outbreak of histamine poisoning after ingestion of the ground saury paste in eight patients taking isoniazid in tuberculous ward. Intern. Med. 44(11): 1133-1136. doi:10.2169/internalmedicine.44.1133. PMID:16357449.
53. Nes, I.F., Diep, D.B., Håvarstein, L.S., Brurberg, M.B., Eijsink, V., and Holo, H. 1996. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie Leeuwenhoek, 70(2-4): 113-128. doi:10.1007/ BF00395929. PMID:8879403.
54. Ohnuma, S., Higa, M., Hamanaka, S., Matsushima, K., and Yamamuro, W. 2001. An outbreak of allergy-like food poisoning. Intern. Med. 40(8): 833-835. doi:10.2169/internalmedicine.40. 833. PMID:11518138.
55. Overbeek, R., Begley, T., Butler, R.M., Choudhuri, J.V., Chuang, H. Y., Cohoon, M., et al. 2005. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 33(17): 5691-5702. doi:10.1093/nar/gki866. PMID:16214803.
56. Pallini, P., Antinucci, C., Pilone, G., Bortoluzzi, F.N., and Saggioro, A. 2005. Celiac disease and nutrition: nutritional status of adult celiac subjects after long lasting gluten free diet(gfd). Gastroenterology, 128(4): A258-A259.
57. Park, J.H., Lee, Y., Moon, E., Seok, S.H., Baek, M.W., Lee, H.Y., et al. 2005. Safety assessment of Lactobacillus fermentum PL9005, a potential probiotic lactic acid bacterium, in mice. J. Microbiol. Biotechnol. 15(3): 603-608.
58. Pessione, E., Mazzoli, R., Giuffrida, M.G., Lamberti, C., Garcia-Moruno, E., Barello, C., et al. 2005. A proteomic approach to studying biogenic amine producing lactic acid bacteria. Proteomics, 5(3): 687-698. doi:10.1002/pmic.200401116. PMID: 15714464.
59. Pridmore, R.D., Pittet, A.C., Praplan, F., and Cavadini, C. 2008. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol. Lett. 283(2): 210-215. doi:10.1111/j.1574-6968.2008.01176.x. PMID: 18435747.
60. Riazi, S., Wirawan, R.E., Badmaev, V., and Chikindas, M.L. 2009. Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J. Appl. Microbiol. 106(4): 1370-1377. doi:10.1111/j.1365-2672.2008.04105.x. PMID:19191946.
61. Rodríguez, E., Arques, J.L., Rodriguez, R., Nunez, M., and Medina, M. 2003. Reuterin production by lactobacilli isolated from pig faeces and evaluation of probiotic traits. Lett. Appl. Microbiol. 37(3): 259-263. doi:10.1046/j.1472-765X.2003.01390.x. PMID: 12904230.
62. Sanders, M.E. 2003. Probiotics: considerations for human health. Nutr. Rev. 61(3): 91-99. doi:10.1301/nr.2003.marr.91-99. PMID:12723641.
63. Schillinger, U., and Lucke, F.K. 1989. Antibacterial activity of Lactobacillus sake isolated from meat. Appl. Environ. Microbiol. 55(8): 1901-1906. PMID:2782870.
64. Schreiber, O., Petersson, J., Phillipson, M., Perry, M., Roos, S., and Holm, L. 2009. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte-and platelet-endothelial cell interactions. Am. J. Physiol. Gastrointest. Liver Physiol. 296(3): G534-G542. doi:10.1152/ajpgi.90470.2008. PMID:19147805.
65. Shornikova, A.V., Casas, I.A., Mykkanen, H., Salo, E., and Vesikari, T. 1997. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 16(12): 1103-1107. doi:10. 1097/00006454-199712000-00002. PMID:9427453.
66. Sjöblom, M., and Nylander, O. 2007. Isoflurane-induced acidosis depresses basal and PGE(2)-stimulated duodenal bicarbonate secretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292(3): G899-G904. doi:10.1152/ajpgi.00398.2006. PMID: 17158257.
67. Song, Y.L., Kato, N., Matsumiya, Y., Liu, C.X., Kato, H., and Watanabe, K. 1999. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J. Clin. Microbiol. 37(9): 3062-3064. PMID:10449509.
68. Talarico, T.L., Casas, I.A., Chung, T.C., and Dobrogosz, W.J. 1988. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 32(12): 1854-1858. doi:10.1128/AAC.32.12.1854. PMID:3245697.
69. Waugh, D.J., and Wilson, C. 2008. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14(21): 6735-6741. doi:10.1158/1078-0432.CCR-07-4843. PMID:18980965.
70. Wolf, C.E., and Gibbons, W.R. 1996. Improved method for quantification of the bacteriocin nisin. J. Appl. Bacteriol. 80(4): 453-457. doi:10.1111/j.1365-2672.1996.tb03242.x. PMID:8849648.
71. Wolf, B.W., Garleb, K.A., Ataya, D.G., and Casas, I.A. 1995. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microb. Ecol. Health Dis. 8(2): 41-50. doi:10.3109/ 08910609509141381.
72. Wolf, B.W., Wheeler, K.B., Ataya, D.G., and Garleb, K.A. 1998. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 36(12): 1085-1094. doi:10.1016/S0278-6915(98) 00090-8. PMID:9862651.
73. Zalán, Z., Németh, E., Baráth, Á., and Halász, A. 2005. Influence of growth medium on hydrogen peroxide and bacteriocin production of Lactobacillus strains. Food Technol. Biotechnol. 43(3): 219-225.